Internal Medicine, Pulmonary Disease · Weston, FL
NPI
1730137597
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2950 Cleveland Clinic Blvd
Weston, FL, 33331
Phone (954) 659-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,723
66 services
Medicare patients, 2024
40
Average age 75
Drug cost, 2024
$7.6M
877 prescriptions
Company payments, 2025
$226
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Franck F Rahaghi was code 99215 (office e&m - established), 20 times for 17 patients. In total Franck F Rahaghi billed 66 services in 8 codes, and Medicare paid $4,723.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 20 | 17 | $119.30 | $2,386 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 15 | 15 | $13.55 | $203 |
| 99214 Office E&M - Established | Facility | 11 | 11 | $74.90 | $824 |
By year: 2022 $104K for 999 services; 2023 $71K for 724 services; 2024 $4,723 for 66 services.
Medicare prescription drug claims, 2024
In 2024, the drug Franck F Rahaghi prescribed most often to Medicare patients was Orenitram Er (Treprostinil Diolamine), with 114 prescriptions and refills. In total Franck F Rahaghi wrote 877 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orenitram Er Treprostinil Diolamine | 114 | 114 | 11 | $1.7M |
| Uptravi Selexipag | 104 | 104 | 11 | $2.1M |
| Opsumit Macitentan | 87 | 87 | 16 | $1.1M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 63 | 79 | 13 | $49K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 49 | 49 | Under 11 | $446K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 30 | 44 | 12 | $997 |
| Sildenafil Citrate Generic | 29 | 37 | Under 11 | $10K |
| Adempas Riociguat | 28 | 28 | Under 11 | $388K |
| Montelukast Sodium Generic | 28 | 65 | 11 | $287 |
| Prednisone Generic | 25 | 36 | 17 | $109 |
| Tyvaso Dpi Treprostinil | 22 | 22 | Under 11 | $523K |
| Ambrisentan Generic | 21 | 21 | Under 11 | $87K |
| Ofev Nintedanib Esylate | 20 | 20 | Under 11 | $259K |
| Mycophenolate Mofetil Generic | 18 | 28 | Under 11 | $1,366 |
| Tadalafil Generic | 18 | 18 | Under 11 | $1,687 |
Brand drugs: 618 claims; generic drugs: 259 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Franck F Rahaghi $226 ($226 in general payments such as food, travel and fees) from 2 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $168.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $57.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.